This compound is primarily used in pharmaceutical research and development, particularly in the synthesis of complex molecules. It serves as a key intermediate in the production of active pharmaceutical ingredients (APIs) due to its boronic acid group, which facilitates Suzuki-Miyaura cross-coupling reactions. These reactions are essential for constructing carbon-carbon bonds, enabling the creation of diverse drug candidates. Additionally, its pyridine ring structure contributes to its stability and reactivity, making it valuable in designing compounds with potential therapeutic applications. It is also employed in material science for developing organic electronic materials and catalysts.